Dexmethylphenidate Hydrochloride is Used for treating attention deficit disorder and/or attention deficit hyperactivity disorder with once daily extended release dosages or bi-modal/pulsatile release compositions. It was first introduced by Sandoz Inc in its drug Focalin on Nov 13, 2001. Another drug containing Dexmethylphenidate Hydrochloride is Focalin Xr. 20 different companies have introduced drugs containing Dexmethylphenidate Hydrochloride.

Dexmethylphenidate Hydrochloride Patents

Given below is the list of patents protecting Dexmethylphenidate Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Focalin Xr	US6228398	Multiparticulate modified release composition	Nov 01, 2019 (Expired)	Sandoz
Focalin Xr	US6730325	Multiparticulate modified release composition	Nov 01, 2019 (Expired)	Sandoz
Focalin	US5908850	Method of treating attention deficit disorders with d-threo methylphenidate	Dec 04, 2015 (Expired)	Sandoz
Focalin	US6355656	Phenidate drug formulations having diminished abuse potential	Dec 04, 2015 (Expired)	Sandoz
Focalin	US6528530	Phenidate drug formulations having diminished abuse potential	Dec 04, 2015 (Expired)	Sandoz
Focalin Xr	US5837284	Delivery of multiple doses of medications	Dec 04, 2015 (Expired)	Sandoz
Focalin Xr	US5908850	Method of treating attention deficit disorders with d-threo methylphenidate	Dec 04, 2015 (Expired)	Sandoz
Focalin Xr	US6355656	Phenidate drug formulations having diminished abuse potential	Dec 04, 2015 (Expired)	Sandoz
Focalin Xr	US6528530	Phenidate drug formulations having diminished abuse potential	Dec 04, 2015 (Expired)	Sandoz
Focalin Xr	US6635284	Delivery of multiple doses of medications	Dec 04, 2015 (Expired)	Sandoz
Focalin Xr	US7431944	Delivery of multiple doses of medications	Dec 04, 2015 (Expired)	Sandoz

Add above patents to watchlist

Dexmethylphenidate Hydrochloride's Family Patents

Full family tree

Dexmethylphenidate Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Dexmethylphenidate Hydrochloride. The first generic version for Dexmethylphenidate Hydrochloride was by Teva Pharmaceuticals Usa and was approved on Jan 29, 2007. And the latest generic version is by Ascent Pharmaceuticals Inc and was approved on Dec 8, 2021.

Given below is the list of companies who have filed for Dexmethylphenidate Hydrochloride generic, along with the locations of their manufacturing plants worldwide.